November 15, 2019   ISSUE ALERT Volume 44, Issue 18 Check out the digital edition!   Gel stent proves value in refractory OAG The subconjunctival gelatin stent (Xen45 Gel Stent, Allergan) is a valuable addition to the glaucoma specialist’s surgical armamentarium because it provides a safe, effective, and predictable means of creating a new pathway for aqueous humor drainage in eyes with an atrophic collector system. Read on   The Magnificent 7: How many glaucoma medications are too many? Finding the sweet spot surrounding the number of anti-glaucoma medications translates to a balancing act with focus on individual patient needs. Find out more   Casting a net to diagnose, treat cancerous lesions Ultra-low-dose radiation therapy is showing promises as a treatment for low-grade lymphoma of the orbit and ocular surface. Learn more   JOB OPPORTUNITIES   VT - University of Vermont